Guidelines for reducing the risk of viral transmission during fertility treatment

Fertility and Sterility

Volumn 86, Issue 5 SUPPL., 2006, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; ESTROGEN; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS C VACCINE; IMMUNOGLOBULIN; PEGINTERFERON; PEGINTERFERON ALPHA; RIBAVIRIN; TENOFOVIR; UNCLASSIFIED DRUG; VALACICLOVIR; WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CANCER; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL ASSESSMENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FERTILIZATION IN VITRO; GENITAL TRACT CANCER; GENITAL TRACT INFECTION; HEALTH CARE FACILITY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HERPES VIRUS INFECTION; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOPROPHYLAXIS; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFERTILITY; INFERTILITY THERAPY; INTRAUTERINE INSEMINATION; LABORATORY TEST; MATERNAL CARE; NEISSERIA GONORRHOEAE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; SEMEN ANALYSIS; SEXUALLY TRANSMITTED DISEASE; SPERMATOZOON MOTILITY; SQUAMOUS CELL CARCINOMA; TREPONEMA PALLIDUM; TRICHOMONAS VAGINALIS; VAGINITIS; VIREMIA; VIRUS CARCINOGENESIS; VIRUS EXAMINATION; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS; WESTERN BLOTTING;

HUMANS; INFERTILITY; REPRODUCTIVE TECHNIQUES; RISK REDUCTION BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; VIRUS DISEASES;

EID: 33750081139     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.07.1485     Document Type: Article

References (47)

1. Ethics Committee of the American Society for Reproductive Medicine. Human immunodeficiency virus and infertility treatment. Fertil Steril 77 (2002) 218-222
2. Politch J.A., and Anderson D.J. Use of assisted reproductive technology to prevent the transmission of HIV-1 in HIV-1 discordant couples desiring children. In: Arici A. (Ed). Immunology and Allergy Clinics of North America vol 22(3 (2002), W.B. Saunders, Philadelphia 663-679
3. Sauer M.V. Providing fertility care to those with HIV: time to re-examine healthcare policy. Am J Bioeth 3 (2003) 33-40
4. Duerr A., and Jamieson D. Assisted reproductive technologies for HIV-discordant couples. Am J Bioeth 3 (2003) 45-47
5. Food and Drug Administration. Part 1271-Human Cells, Tissues and Cellular and Tissue Based Products; Donor Screening and Testing, and Related Labeling; Interim Final Rule 5/24/05. Federal Register vol 70, no. 100, May 25, 2005, Rules and Regulations. http://www.fda.gov/cber/tissue/docs.htm.
6. Clarke G.N. Sperm cryopreservation: is there a significant risk of cross-contamination?. Hum Reprod 14 (1999) 2941-2943
7. Blank S., Simonds R.J., Weisfuse I., Rudnick J., Chiasson M.A., and Thomas P. Possible nosocomial transmission of HIV. Lancet 344 (1994) 512-514
8. Lesourd F., Izopet J., Mervan C., Payen J.L., Sandres K., Monrozies X., et al. Transmissions of hepatitis C virus during the ancillary procedures for assisted conception. Hum Reprod 15 (2000) 1083-1085
9. Tedder R.S., Zuckerman M.A., Goldstone A.H., Hawkins A.E., Fielding A., Briggs E.M., et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 346 (1995) 137-140
10. Englert Y., Lesage B., Van Vooren J.P., Liesnard C., Place I., Vannin A.S., et al. Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update 10 (2004) 149-162
11. Semprini A.E., Levi-Setti P., Bozzo M., Ravizza M., Taglioretti A., Sulpizio P., et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340 (1992) 1317-1319
12. Politch J.A., Xu C., Tucker L., and Anderson D.J. Separation of human immunodeficiency virus type 1 from motile sperm by the double tube gradient method vs other methods. Fertil Steril 81 (2004) 440-447
13. Marina S., Marina F., Alcolea R., Exposito R., Huguet J., Nadal J., et al. Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 70 (1998) 35-39
14. Pasquier C., Daudin M., Righi L., Berges L., Thauvin L., Berrebi A., et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS 14 (2000) 2093-2099
15. Royce R.A., Sena A., Cates W., and Cohen M.S. Sexual transmission of HIV. N Engl J Med 336 (1997) 1072-1078
16. Galvin S.R., and Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2 (2004) 33-42
17. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., et al., Rakai Project Study Group. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 342 (2000) 921-929
18. Coombs R.W., Speck C.E., Hughes J.P., Lee W., Sampoleo R., Ross S.O., et al. Association between culturable human immunodeficiency virus type I (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 177 (1998) 320-330
19. Anderson D.J., O'Brien T.R., Politch J.A., Martinez A., Seage G.R., Padian N., et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA 267 (1992) 2769-2774
20. Zhang H., Dornadula G., Beumont M., Livornese L., Van Uitert B., Henning K., et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 339 (1998) 1803-1809
21. Wortley P.M., Hammett T.A., and Fleming P.L. Donor insemination and human immunodeficiency virus transmission. Obstet Gynecol 91 (1998) 515-518
22. Quayle A.J., Xu C., Mayer K.H., and Anderson D.J. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 176 (1997) 960-968
23. Gilling-Smith C., Frodsham L.C.G., Tambrlin B., Cox A., Rozis G., and Almeida P.A. Reducing reproductive risks in HIV infected couples: a comprehensive programme of care. Hum Reprod 18 Suppl 1 (2003) P404
24. Sauer M.V. Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review. Reprod Biomed Online 10 (2005) 135-140
25. Sewankambo N., Gray R.H., Wawer M.J., Paxton L., McNaim D., Wabwire-Mangen F., et al. HIV-1 infection associated with abnormal vaginal flora morhphology and bacterial vaginosis. Lancet 350 (1997) 546-550
26. Baleta A. Concern voiced over "dry sex" practices in South Africa. Lancet 352 (1998) 1292
27. Jackson J.B., Barnett S., Piwowar-Manning E., Apuzzo L., Raines C., Hendrix C., et al. A phase I/II study of neverapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk. AIDS 17 (2003) 547-553
28. Youle M., and Wainberg M.A. Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy. J Int Assoc Physicians AIDS Care 2 (2003) 102-105
29. Dando T.M., and Wagstaff A.J. Emtricitabine/tenofovir disoproxil fumarate. Drugs 64 (2004) 2075-2082
30. Smith S.M., Mefford M., Sodora D., Klase Z., Singh M., Alexander N., et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 18 (2004) 1637-1643
31. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., et al., Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331 (1994) 1173-1180
32. Custer B., Sullivan S.D., Hazlet T.K., Iloeje U., Veenstra D.L., and Kowdley K.V. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38 10 Suppl (2004) S158-S168
33. Mosley J.W. The epidemiology of viral hepatitis: an overview. Am J Med Sci 270 (1975) 253-270
34. Berry W., Gottesfeld R., Alter H., and Vierling J. Transmission of hepatitis B virus by artificial insemination. JAMA 257 (1987) 1079-1081
35. Lemon S.M., and Alter M.J. Viral Hepatitis. In: Holmes K.K., Mardh P.A., Sparling P.F., Lemon S.M., Stamm W.E., Piot P., and Wasserheit J.N. (Eds). Sexually Transmitted Diseases. Third Edition (1999), McGraw-Hill, publ 361-384
36. Shukla N.B., and Poles M.A. Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus. Clin Liver Dis 8 (2004) 445-460
37. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 40 RR-13 (1991) 1-25
38. Bresters D., Mauser-Bunschoten E.P., Reesink H.W., Roosendaal G., van der Poel C.L., Chamuleau R.A., et al. Sexual transmission of hepatitis C virus. Lancet 342 (1993) 210-211
39. MacDonald M., Crofts N., and Kaldor J. Transmission of hepatitis C virus: rates, routes, and co-factors. Epidemiol Rev 18 (1996) 137-148
40. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
41. Foster G.R. Past, present, and future of hepatitis C treatments. Sem Liver Dis 24 Suppl 2 (2004) 97-104
42. Cleghorn F.R., and Blattner W.A. Human T-cell lymphotropic virus and HTLV infection. In: Holmes K.K., Mardh P.A., Sparling P.F., Lemon S.M., Stamm W.E., Piot P., and Wasserheit J.N. (Eds). Sexually Transmitted Diseases. Third Edition (1999), McGraw-Hill, publ 259-268
43. Molijn A., Kleter B., Quint W., and van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32 Suppl 1 (2005) S43-S51
44. Pertel P.E., and Spear P.G. Biology of Herpesviruses. In: Holmes K.K., Mardh P.A., Sparling P.F., Lemon S.M., Stamm W.E., Piot P., and Wasserheit J.N. (Eds). Sexually Transmitted Diseases. Third Edition (1999), McGraw-Hill, publ 215-230
45. Bale J.F., and Miner L.J. Herpes simplex virus infections of the newborn. Curr Treat Options Neurol 7 (2005) 151-156
46. Corey L., Wald A., Patel R., Sacks S.L., Tyring S.K., Warren T., et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350 (2004) 11-20
47. Cytomegalovirus. National Center for Infectious Diseases, Centers for Disease Control and Prevention 2002. http://www.cdc.gov/ncidod/diseases/cmv.htm.